BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 4274256)

  • 1. An in vitro study of lymphocyte and macrophage function with lymphoproliferative neoplasms.
    Twomey JJ; Douglass CC
    Cancer; 1974 Apr; 33(4):1034-8. PubMed ID: 4274256
    [No Abstract]   [Full Text] [Related]  

  • 2. Lymphocyte surface markers in lymphoproliferative disorders.
    Aiuti F; Lacava V; Fiorilli M; Ciarla MV
    Acta Haematol; 1973; 50(5):275-83. PubMed ID: 4202631
    [No Abstract]   [Full Text] [Related]  

  • 3. The macrophage aggregation assay for cell-mediated immunity in man. Studies of patients with Hodgkin's disease and sarcoidosis.
    Gotoff SP; Lolekha S; Lopata M; Kopp J; Kopp RL; Malecki TJ
    J Lab Clin Med; 1973 Oct; 82(4):682-91. PubMed ID: 4585463
    [No Abstract]   [Full Text] [Related]  

  • 4. [T and B lymphocytes in humans. Lymphocytes with membrane immunoglobulins in normal and pathological conditions].
    Aiuti F; Lacava V; D'Asero C; Ciarla MV; D'Amelio R; Fiorilli M
    Recenti Prog Med; 1973 Feb; 54(2):124-51. PubMed ID: 4541383
    [No Abstract]   [Full Text] [Related]  

  • 5. An overview of cancer immunology.
    Ritts RE; Neel HB
    Mayo Clin Proc; 1974 Feb; 49(2):118-31. PubMed ID: 4591299
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immunological aspects of malignant lymphoproliferative diseases].
    Rivero I; Diumenjo M
    Rev Clin Esp; 1977 Mar; 144(6):403-9. PubMed ID: 140441
    [No Abstract]   [Full Text] [Related]  

  • 7. Familiar B-cell neoplasms and HLA antigens.
    Nigro M; De Rosa G; Camera A; Minerva A; Venuta S; Rotoli B
    Haematologica; 1985; 70(5):465. PubMed ID: 3937792
    [No Abstract]   [Full Text] [Related]  

  • 8. Impaired delayed hypersensitivity in juvenile rheumatoid arthritis.
    Höyeraal HM
    Ann Rheum Dis; 1973 Jul; 32(4):331-6. PubMed ID: 4199237
    [No Abstract]   [Full Text] [Related]  

  • 9. Mixed lymphocyte culture stimulatory and responding capacity of lymphocytes from patients with lymphoproliferative diseases.
    Rühl H; Vogt W; Bochert G; Schmidt S; Moelle R; Schaoua H
    Clin Exp Immunol; 1975 Jan; 19(1):55-65. PubMed ID: 128426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired immunoresponsiveness in tumor patients.
    Harris J; Copeland D
    Ann N Y Acad Sci; 1974; 230():56-85. PubMed ID: 4595955
    [No Abstract]   [Full Text] [Related]  

  • 11. Serum migration-inhibitory activity in patients with lymphoproliferative diseases.
    Cohen S; Fisher B; Yoshida T; Bettigole RE
    N Engl J Med; 1974 Apr; 290(16):882-6. PubMed ID: 4593612
    [No Abstract]   [Full Text] [Related]  

  • 12. Leukemia - definition and characterization from the comparative viewpoint.
    Dameshek W
    Bibl Haematol; 1970; (36):1-10. PubMed ID: 4950965
    [No Abstract]   [Full Text] [Related]  

  • 13. Delayed hypersensitivity in chronic lymphocytic leukemia.
    Block JB; Haynes HA; Thompson WL; Neiman PE
    J Natl Cancer Inst; 1969 Jun; 42(6):973-80. PubMed ID: 5797552
    [No Abstract]   [Full Text] [Related]  

  • 14. HL-A antigens and hematologic malignancy.
    Miller WV
    Arch Intern Med; 1974 Mar; 133(3):397-9. PubMed ID: 4521322
    [No Abstract]   [Full Text] [Related]  

  • 15. [Blastic lymphocyte transformation caused by phytohemagglutinin in patients with lymphoproliferative diseases].
    Mantovani G; Petrini MT; Tognella S; Grifoni V
    Boll Soc Ital Biol Sper; 1972 Jul; 48(14):381-5. PubMed ID: 4628299
    [No Abstract]   [Full Text] [Related]  

  • 16. Reduced in vivo cell-mediated immune responses to mumps, tuberculin, and streptokinase/streptodornase but not to Candida albicans in oral lichen planus.
    Simark-Mattsson C; Jontell M; Bergenholtz G; Dahlgren UI
    J Dent Res; 1999 Nov; 78(11):1704-10. PubMed ID: 10576166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactivity of lymphocytes from primary neoplasms of lymphoid tissues.
    Twomey JJ; Laughter AH; Lazar S; Douglass CC
    Cancer; 1976 Aug; 38(2):740-7. PubMed ID: 135638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunological and clinical differences between lymphoblastic leukemia and lymphoma originating from non-T, non-B cells, T cells and B cells].
    Rupniewska ZM; Kniaź M
    Postepy Hig Med Dosw; 1980; 34(2):119-41. PubMed ID: 7017639
    [No Abstract]   [Full Text] [Related]  

  • 19. The immunological and cytochemical characterization of T-cell lymphoproliferative diseases.
    Spira TJ; Ades EW; Gordon DS
    Am J Hematol; 1981; 10(1):19-30. PubMed ID: 6455061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pathogenesis of immunologic deficiency diseases associated with lymphoproliferative disorders].
    Ponzone A; Tarocco RP; Nicola P
    Minerva Pediatr; 1970 Dec; 22(51):2542-60. PubMed ID: 4993895
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.